iShares U.S. Pharmaceutic... (IHE)
73.05
0.20 (0.27%)
At close: Mar 04, 2025, 10:56 AM
No 1D chart data available
| Bid | 72.42 |
| Market Cap | 619.91M |
| AUM | 613.22M |
| NAV | 70.08 |
| EPS (ttm) | 2.74 |
| PE Ratio (ttm) | 26.64 |
| Shares Out | 8.49M |
| Inception Date | May 5, 2006 |
| Ask | 73.1 |
| Volume | 47.8K |
| Open | 72.54 |
| Previous Close | 72.85 |
| Day's Range | 72.50 - 73.08 |
| 52-Week Range | 62.68 - 73.28 |
| Holdings | 45 |
| Expense Ratio | 0.39% |
About IHE
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Asset Class Equity
Ticker Symbol IHE
Inception Date May 5, 2006
Provider Blackrock
Website Fund Home Page
Top 10 Holdings 81.81% of assets
| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly And Compan... | 25.19% | |
| Johnson & Johnson | 24.51% | |
| Bristol-myers Squibb... | 4.58% | |
| Pfizer Inc. | 4.56% | |
| Royalty Pharma Plc | 4.39% | |
| Intra-cellular Thera... | 4.32% | |
| Zoetis Inc. | 4.11% | |
| Merck & Co., Inc. | 4.03% | |
| Viatris Inc. | 3.15% | |
| Jazz Pharmaceuticals... | 2.97% |
Dividends Dividend Yield 1.7%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 17, 2024 | $0.2108 | Dec 20, 2024 |
| Sep 25, 2024 | $0.3589 | Sep 30, 2024 |
| Jun 11, 2024 | $0.2940 | Jun 17, 2024 |
| Mar 21, 2024 | $0.2750 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1347 | Dec 27, 2023 |
